News & Updates
Filter by Specialty:
Show Multimedia Only
Can very low-risk breast cancer patients be spared from postop radiotherapy?
12 Jul 2022
byAudrey Abella
Adjuvant radiotherapy (RT) may be omitted in women with very low-risk breast cancer who have had breast conserving surgery (BCS) and have been receiving endocrine therapy, according to findings from the LUMINA study.
Can very low-risk breast cancer patients be spared from postop radiotherapy?
12 Jul 2022
Cobalt, antimony exposure ups erectile dysfunction risk
12 Jul 2022
byTristan Manalac
High levels of exposure to the heavy metals cobalt and antimony appears to increase the risk of developing erectile dysfunction (ED), according to a new study.
Cobalt, antimony exposure ups erectile dysfunction risk
12 Jul 2022
Camostat mesylate flops against SARS-CoV-2
12 Jul 2022
The serine protease inhibitor camostat mesylate does not appear to be an effective antiviral agent in patients with early-phase COVID-19, having failed to stop SARS-CoV-2 in its tracks in a phase II trial.
